TALPHERA, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
TALPHERA, INC. (TLPH) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.83 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-12
- TALPHERA, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.81.
- TALPHERA, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- TALPHERA, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $1.03, a 41.48% decline year-over-year.
- TALPHERA, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.76, a 340.00% increase year-over-year.
- TALPHERA, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.70, a 32.04% decline from fiscal 2024.
- TALPHERA, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $1.03, a 38.32% decline from fiscal 2023.
- TALPHERA, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $1.67.
- TALPHERA, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $1.82, a 40.00% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.83 10-Q · filed 2026-08-12 | |||
| 2026-03-31 | $0.81 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $0.70 10-K · filed 2026-03-23 | |||
| 2025-09-30 | $0.58 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | $0.58 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | |||
| 2024-12-31 | $1.03 10-K · filed 2026-03-23 | |||
| 2024-09-30 | $1.03 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | $1.03 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | $1.03 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | $1.67 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $1.76 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $1.76 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | $1.76 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | $7.75 8-K · filed 2023-08-01 | |||
| 2022-09-30 | $7.80 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $0.40 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $0.40 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | $1.82 10-K · filed 2022-03-10 | |||
| 2020-12-31 | $1.30 10-K · filed 2021-03-15 | |||
| 2019-12-31 | $2.53 10-K · filed 2020-03-16 | |||
| 2018-12-31 | $2.28 10-K · filed 2019-03-07 | |||
| 2017-12-31 | $2.99 10-K · filed 2018-03-09 | |||
| 2016-12-31 | $3.25 10-K · filed 2017-03-03 | |||
| 2015-12-31 | $4.28 10-K · filed 2016-03-07 | |||
| 2014-12-31 | $8.74 10-K · filed 2015-03-13 | |||
| 2013-12-31 | $5.99 10-K · filed 2015-03-13 | |||
| 2012-12-31 | $3.36 10-K · filed 2015-03-13 | |||
| 2011-12-31 | $3.48 10-K · filed 2014-03-17 | |||
| 2010-12-31 | $2.72 10-K · filed 2013-03-12 | |||
| 2009-12-31 | $5.52 10-K · filed 2013-03-12 | |||
| 2008-12-31 | $4.00 10-K · filed 2013-03-12 | |||
| 2007-12-31 | $1.20 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |